{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:51:09Z","timestamp":1791215469615,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI22CIII\/00053"],"award-info":[{"award-number":["PI22CIII\/00053"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijid.2026.108864","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:36:56Z","timestamp":1781023016000},"page":"108864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Establishing thresholds for azole tolerance and persistence in Aspergillus fumigatus to study their impact on voriconazole treatment in vivo"],"prefix":"10.1016","volume":"170","author":[{"given":"Rebeca","family":"Lobo-Vega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Meg\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"R\u00edo-Ropero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Mato-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Ashraph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Manosalva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Alc\u00e1zar-Fuoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Alastruey-Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Mellado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8987-5115","authenticated-orcid":false,"given":"Jorge","family":"Amich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108864_bib0001","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/CMR.00140-18","article-title":"Aspergillus fumigatus and aspergillosis in 2019","volume":"33","author":"Latg\u00e9","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijid.2026.108864_bib0002","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"70","author":"Kosmidis","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.ijid.2026.108864_bib0003","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/imj.15591","article-title":"Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021","volume":"51","author":"Douglas","year":"2021","journal-title":"Intern Med J"},{"key":"10.1016\/j.ijid.2026.108864_bib0004","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108864_bib0005","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2026.108864_bib0006","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2026.108864_bib0007","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108864_bib0008","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108864_bib0009","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aap7999","article-title":"Worldwide emergence of resistance to antifungal drugs challenges human health and food security","volume":"360","author":"Fisher","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ijid.2026.108864_bib0010","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/cid\/ciy859","article-title":"Voriconazole resistance and mortality in invasive aspergillosis: a multicenter retrospective cohort study","volume":"68","author":"Lestrade","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108864_bib0011","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01062-2016","article-title":"Predictors of mortality in chronic pulmonary aspergillosis","volume":"49","author":"Lowes","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2026.108864_bib0012","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/myc.13410","article-title":"Incidence, risk factors and mortality of invasive pulmonary aspergillosis in patients with influenza: a systematic review and meta-analysis","volume":"65","author":"Shi","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.ijid.2026.108864_bib0013","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41579-019-0196-3","article-title":"Definitions and guidelines for research on antibiotic persistence","volume":"17","author":"Balaban","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijid.2026.108864_bib0014","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nrmicro.2016.34","article-title":"Distinguishing between resistance, tolerance and persistence to antibiotic treatment","volume":"14","author":"Brauner","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijid.2026.108864_bib0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mib.2021.09.017","article-title":"Antibiotic persistence and tolerance: not just one and the same","volume":"64","author":"Ronneau","year":"2021","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.ijid.2026.108864_bib0016","doi-asserted-by":"crossref","DOI":"10.1099\/mic.0.001266","article-title":"Bacterial survivors: evaluating the mechanisms of antibiotic persistence","volume":"168","author":"Shi","year":"2022","journal-title":"Microbiology"},{"key":"10.1016\/j.ijid.2026.108864_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2023.102328","article-title":"Antibiotic tolerance: targeting bacterial survival","volume":"74","author":"Boeck","year":"2023","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.ijid.2026.108864_bib0018","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev-micro-020518-115650","article-title":"Bacterial persisters and infection: past, present, and progressing","volume":"73","author":"Gollan","year":"2019","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.ijid.2026.108864_bib0019","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202051034","article-title":"Antibiotic resistance and persistence\u2014implications for human health and treatment perspectives","volume":"21","author":"Huemer","year":"2020","journal-title":"EMBO Rep"},{"key":"10.1016\/j.ijid.2026.108864_bib0020","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/cid\/ciac281","article-title":"Prevalence of antibiotic tolerance and risk for reinfection among Escherichia coli bloodstream isolates: a prospective cohort study","volume":"75","author":"Lazarovits","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108864_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008892","article-title":"Antibiotic tolerance","volume":"16","author":"Westblade","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijid.2026.108864_bib0022","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drup.2015.10.001","article-title":"Defining the frontiers between antifungal resistance, tolerance and the concept of persistence","volume":"23","author":"Delarze","year":"2015","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.ijid.2026.108864_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103953","article-title":"The role of Candida albicans stress response pathways in antifungal tolerance and resistance","volume":"25","author":"Iyer","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.ijid.2026.108864_bib0024","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1038\/s41467-018-04926-x","article-title":"Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia","volume":"9","author":"Rosenberg","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijid.2026.108864_bib0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.00399-19","article-title":"Echinocandins for the treatment of invasive aspergillosis: from laboratory to bedside","volume":"63","author":"Aruanno","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2026.108864_bib0026","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00447-22","article-title":"The caspofungin paradoxical effect is a tolerant \u201ceagle effect\u201d in the filamentous fungal pathogen Aspergillus fumigatus","volume":"13","author":"Valero","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.ijid.2026.108864_bib0027","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04770-22","article-title":"Aspergillus fumigatus Can display persistence to the fungicidal drug voriconazole","volume":"11","author":"Scott","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijid.2026.108864_bib0028","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3390\/jof9080805","article-title":"Potential implication of azole persistence in the treatment failure of two haematological patients infected with Aspergillus fumigatus","volume":"9","author":"Pel\u00e1ez-Garc\u00eda de la Rasilla","year":"2023","journal-title":"J Fungi"},{"key":"10.1016\/j.ijid.2026.108864_bib0029","doi-asserted-by":"crossref","first-page":"E248","DOI":"10.1111\/j.1469-0691.2012.03890.x","article-title":"EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole","volume":"18","author":"Arendrup","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2026.108864_bib0030","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1469-0691.2006.01377.x","article-title":"Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values","volume":"12","author":"Turnidge","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2026.108864_bib0031","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03475-24","article-title":"Toward the consensus of definitions for the phenomena of antifungal tolerance and persistence in filamentous fungi","volume":"16","author":"Amich","year":"2025","journal-title":"mBio"},{"key":"10.1016\/j.ijid.2026.108864_bib0032","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1086\/381972","article-title":"Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of gram-positive bacterial infections","volume":"38","author":"Pankey","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108864_bib0033","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.riam.2016.04.001","article-title":"The role of epidemiological cutoff values (ECVs\/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds","volume":"33","author":"Espinel-Ingroff","year":"2016","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.ijid.2026.108864_bib0034","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ijantimicag.2015.07.007","article-title":"In vivo efficacy of voriconazole and posaconazole therapy in a novel invertebrate model of Aspergillus fumigatus infection","volume":"46","author":"Forastiero","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2026.108864_bib0035","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/AAC.42.11.3018","article-title":"Organism-dependent fungicidal activities of azoles","volume":"42","author":"Manavathu","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2026.108864_bib0036","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.1038\/s41467-024-50609-1","article-title":"Toxic eburicol accumulation drives the antifungal activity of azoles against Aspergillus fumigatus","volume":"15","author":"Elsaman","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijid.2026.108864_bib0037","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1128\/AAC.01512-07","article-title":"In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species","volume":"52","author":"Js","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2026.108864_bib0038","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/IDR.S102207","article-title":"Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations","volume":"9","author":"Krishnan Natesan","year":"2016","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijid.2026.108864_bib0039","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/microorganisms8030390","article-title":"Galleria mellonella for the evaluation of antifungal efficacy against medically important fungi, a narrative review","volume":"8","author":"Jemel","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijid.2026.108864_bib0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/mmy\/myy042","article-title":"Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment","volume":"57","author":"Maurer","year":"2019","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijid.2026.108864_bib0041","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.01250-17","article-title":"Single-center evaluation of an agar-based screening for azole resistance in Aspergillus fumigatus by using VIPcheck","volume":"61","author":"Buil","year":"2017","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226004996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226004996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:54:30Z","timestamp":1791212070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226004996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":41,"alternative-id":["S1201971226004996"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108864","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishing thresholds for azole tolerance and persistence in Aspergillus fumigatus to study their impact on voriconazole treatment in vivo","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108864","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108864"}}